FIG 1.
Generation of a comprehensive collection of esophagogastric cancer PDXs. (A) Schematic overview of esophagogastric cancer PDX pipeline. (B) Numbers of successfully established PDX by disease subtype. (C) Distribution of procedures from which PDXs were generated. (D) Distribution of PDXs generated from primary tumors versus metastatic sites. (E) Numbers of PDXs generated by metastatic site of origin. (F) Treatment status of PDXs from patients treated for early-stage (I-III) disease. (G) Treatment status of PDXs from patients treated for metastatic disease. PDX, patient-derived xenograft.